Global Parenteral Nutrition Market Outlook, 2030

The global parenteral nutrition market is set for significant expansion by 2030, driven by a rise in occurrences of chronic diseases, malnutrition, and preterm births. Parenteral nutrition (PN) involves the intravenous delivery of vital nutrients, including proteins, carbohydrates, fats, vitamins, and minerals, to individuals who cannot receive sufficient nutrition via oral or enteral methods. This essential therapy is commonly utilized in hospitals, home healthcare environments, and intensive care units (ICUs), particularly for critically ill individuals, those undergoing major surgical procedures, cancer patients, and neonates with immature digestive systems. A key factor fueling the parenteral nutrition market is the increasing prevalence of chronic conditions such as gastrointestinal issues, cancer, and metabolic disorders, which hinder normal food absorption. The rising global issue of malnutrition, especially among infants and the elderly, has also led to a heightened demand for PN solutions. The World Health Organization (WHO) reports that malnutrition continues to be a significant public health concern, especially in low and middleincome countries (LMICs), creating a greater need for effective nutritional support therapies.

Garnering 4.1% from 2022 to 2028, the global parenteral nutrition market is projected to reach worth of USD 7,302 million by 2028. Innovations in parenteral nutrition formulations and delivery methods are further driving market growth. The creation of customized parenteral nutrition options designed for specific patient requirements has greatly enhanced treatment results. Moreover, the launch of lipid emulsions with superior fatty acid compositions and multichamber bags that improve safety and efficiency in PN delivery are transforming the sector. The movement towards homebased parenteral nutrition (HPN) is a notable emerging trend, enabling patients to receive PN in a managed environment outside of hospitals, thereby lowering healthcare costs and enhancing quality of life. Key participants in the parenteral nutrition market include Baxter International Inc. , Fresenius Kabi, B. Braun Melsungen AG, Pfizer Inc. , and ICU Medical, Inc. These firms are actively involved in strategic partnerships, product launches, and expansion initiatives to enhance their market position. The increasing trend of personalized nutrition therapy, along with the rising demand for nutritional products customized for specific patient demographics, is anticipated to further influence market dynamics.

The global parenteral nutrition (PN) market is increasing across multiple regions, with North America, Europe, AsiaPacific, Latin America, and the Middle East and Africa being the primary markets. Each area contributes to market expansion through technological innovations, growing healthcare investments, and rising occurrences of chronic illnesses and malnutrition. North America leads the global PN market, propelled by sophisticated healthcare infrastructure, substantial healthcare expenditures, and a robust presence of key market players. The United States heads the region due to increasing instances of chronic diseases, heightened adoption of homebased PN, and governmental efforts promoting clinical nutrition. Canada also plays a significant role, with growing awareness and access to premium PN solutions. Europe stands out as another significant region, with Germany, the UK, France, and Italy holding important positions. The market gains from an established healthcare system, an aging population, and strong governmental backing for nutritional therapies. The rising occurrence of gastrointestinal disorders and cancer in European nations has propelled the demand for PN solutions. The AsiaPacific region is anticipated to experience the fastest growth rate due to enhanced healthcare infrastructure, increased awareness regarding PN, and escalating cases of malnutrition and chronic diseases. China, India, and Japan are critical players, with government programs aimed at enhancing neonatal and critical care services. Rapid urbanization and an aging demographic further boost market growth in this area. The LAMEA region is seeing consistent growth because of better healthcare access and climbing malnutrition rates. Nations like Brazil, Mexico, South Africa, and the UAE are channeling investments into broadening healthcare services, raising the uptake of PN therapies, and addressing the nutritional requirements of children and the elderly.

Parenteral nutrition comprises several vital components necessary for sustaining appropriate metabolic function and fulfilling nutritional requirements. Carbohydrates, mainly provided as dextrose, act as the primary energy resource in PN solutions, assisting in the prevention of protein breakdown and muscle deterioration. Parenteral lipid emulsions supply essential fatty acids and calories, promoting cell membrane functionality and mitigating inflammation. Singledose amino acid solutions are essential for muscle recovery and protein formation, especially in critically ill individuals. Trace elements, like zinc, copper, selenium, and chromium, are crucial for enzyme activity and immune assistance. Vitamins and minerals facilitate adequate metabolic function, neurological activity, and bone wellness, especially for longterm PN users. The growing availability of customized PN formulations tailored to individual patient requirements is improving overall clinical outcomes and stimulating market expansion. The parenteral nutrition market caters to two primary consumer groups: adults and children/newborns. Adult patients, including those living with cancer, gastrointestinal issues, or postoperative complications, frequently depend on PN to sustain sufficient nutrition. Critically ill adults in ICUs also gain from PN when enteral feeding is not feasible. The rising incidence of malnutrition and metabolic issues in the elderly population has further escalated demand. Conversely, children and newborns, particularly preterm infants, necessitate PN to promote development, organ maturation, and overall health. Neonatal PN is vital for infants with low birth weight or congenital gastrointestinal conditions. The increasing survival rates of premature infants due to advancements in neonatal care have resulted in a higher utilization of PN in pediatric medicine. Hospitals and clinics continue to be the primary end users of parenteral nutrition, as nearly all critically ill patients necessitate careful monitoring and specialized healthcare services. Patients in intensive care units (ICUs), those recovering from surgery, or individuals receiving chemotherapy commonly undergo PN in hospital environments. Longterm condition care, including nursing homes and rehabilitation facilities, represents another expanding segment, fueled by an aging populace and the rising prevalence of chronic ailments such as cancer, Crohn’s disease, and severe malabsorption disorders. These institutions offer prolonged nutritional support to patients who cannot sustain oral intake. The home care sector is also experiencing swift growth due to the increasing trend of homebased parenteral nutrition (HPN), which enables individuals with chronic conditions, postoperative issues, or neurological ailments to obtain PN in the comfort of their residences. Improvements in portable infusion pumps and home healthcare services are enhancing the accessibility of HPN, elevating patient ease, and minimizing hospital durations.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030



Aspects covered in this report
• Global Parenteral Nutrition Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By type:
• carbohydrates
• parenteral lipid emulsion
• single dose amino acid solution
• trace elements
• vitamins & minerals

By consumer:
• adults
• children and newbowns

By end user:
• hospitals & clinics
• long term conditions care
• home care

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to agriculture industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.